FISH OIL TRIGLYCERIDES: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fresenius Kabi Usa	OMEGAVEN	fish oil triglycerides	EMULSION;INTRAVENOUS	210589	NDA	Fresenius Kabi USA, LLC	63323-205-00	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-205-00) / 100 mL in 1 VIAL, SINGLE-DOSE (63323-205-31)	2018-07-27
Fresenius Kabi Usa	OMEGAVEN	fish oil triglycerides	EMULSION;INTRAVENOUS	210589	NDA	Fresenius Kabi USA, LLC	63323-205-50	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-205-50) / 50 mL in 1 VIAL, SINGLE-DOSE (63323-205-21)	2018-07-27
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: May 29, 2026

ecutive summary: Fish oil triglycerides is a commodity-style active ingredient supplied by multiple contract manufacturers and ingredient oil refiners across the US, EU, and Asia. The supply chain is driven by (1) sustainable sourcing and traceability of feedstock, (2) purification and contaminant controls for heavy metals and oxidation products, and (3) the ability to produce consistent triglyceride-form concentrates that meet pharmacopoeial and finished-product specifications. Key supplier categories include branded API manufacturers, bulk fish oil refiners, and FDA-registered/CGMP contract manufacturers that convert refined oil into pharmaceutical-grade triglyceride concentrates or encapsulated dosage forms.

Scope note: The term “fish oil triglycerides” can refer to triglyceride omega-3 concentrates (often EPA/DHA-rich) used as an active ingredient in drug products. This article covers supplier landscape categories, typical qualifying requirements, and diligence points used to assess supplier readiness for pharmaceutical use.

Who supplies pharmaceutical fish oil triglycerides (EPA/DHA triglycerides)?

Short answer: Suppliers are typically (a) omega-3 refiners that produce triglyceride-form concentrates (API/bulk intermediate), and (b) CDMOs that further process, encapsulate, and package under CGMP for drug sponsors. In practice, drug sponsors often qualify one or more upstream refiners and one or more downstream CGMOs.

Upstream omega-3 triglyceride concentrate suppliers

Upstream suppliers generally provide one of the following:

Refined fish oil (triglyceride form) with standardized EPA/DHA content.
Concentrated triglyceride omega-3 (often via molecular distillation and/or further fractionation).
Pharmaceutical-grade bulk meeting pharmacopeial-like specifications for oxidation, purity, and contaminant profiles.

Key differentiators:

Oxidation control strategy (peroxide value, anisidine value, TOTOX or equivalent).
Heavy metal controls (lead, mercury, cadmium, arsenic).
Halogenated contaminants and persistent organic pollutants testing where required by finished product specifications.
Batch-to-batch consistency in triglyceride composition and EPA/DHA profile.

Downstream pharmaceutical manufacturers (CDMOs/packagers)

Downstream players provide:

Encapsulation (softgels are common) and compression/tableting if the formulation uses lipid excipients.
Filling, coating, and secondary packaging aligned with drug product stability needs.
Analytical release testing and stability program support.

Key differentiators:

Lipid handling capability under controlled oxygen/light exposure.
In-process controls for encapsulation fill weight, seal integrity, and oxidation rise.
Stability-indicating methods for omega-3 degradation.

How do pharmaceutical fish oil triglycerides suppliers qualify under CGMP and FDA expectations?

Short answer: Qualification is usually vendor-by-vendor through supplier audits, document packages (CoA/specs), and verification that raw material and intermediates meet drug-grade contaminant and oxidation requirements, with controlled change management.

Core qualification documents sponsors request

GMP status evidence and quality agreements.
Certificates of analysis (CoA) for representative lots.
Specification sheets for:
- EPA/DHA content and identity
- Triglyceride composition profile (where used by the sponsor)
- Oxidation indices
- Heavy metals
- Microbial/bioburden controls if relevant to process
Traceability documentation for feedstock.
Change control procedures and batch records access rules.

Typical quality systems and controls

Incoming raw material risk assessment.
In-process sampling plan and acceptance criteria.
Defined retest periods and rejection criteria for out-of-spec lots.
Supplier deviation handling and CAPA process.

What specifications and contaminant limits matter most for fish oil triglycerides used as a drug ingredient?

Short answer: Drug-grade fish oil triglycerides are screened for oxidation and purity (EPA/DHA strength and identity) plus contaminant limits, particularly heavy metals. Many finished products also include limits for oxidation markers and stability-related parameters.

Purity and identity

EPA and DHA percentage range(s) by method used in the finished product spec.
Triglyceride identity checks and lipid class profiling where relevant.

Oxidation control

Commonly controlled oxidation metrics include:

Peroxide value and/or TOTOX-like composite measures.
Anisidine value (or related aldehydes).
Monitoring for free fatty acids trend and overall degradation products.

Contaminants

Heavy metals: lead, mercury, cadmium, arsenic.
Other impurities are assessed based on regulatory strategy and source risk profiling, including marine contaminants where specified by finished product requirements.

Which fish oil triglycerides suppliers have the strongest track record for pharmaceutical-grade omega-3?

Short answer: The strongest suppliers in practice are those with:

Demonstrated supply history to pharma or to drug sponsors (not only dietary supplements),
Documented CGMP manufacturing,
Controlled feedstock sourcing and robust analytical release testing.

Supplier selection scoring used in pharma procurement

Evidence of pharmaceutical-grade CGMP operations (not only food/supplement).
Analytical method capability for oxidation, identity, and contaminants.
Ability to support regulatory filings via CoA history and change reporting.
Technical transfer support for consistent triglyceride concentrate production.

What sourcing and sustainability requirements affect fish oil triglycerides suppliers?

Short answer: Many pharma supply strategies require traceability of fisheries, consistent feedstock, and documentation that sourcing is managed to reduce variability in contaminant load and composition.

Feedstock controls that suppliers commonly implement

Supplier audits for fishing operations and suppliers of crude oil.
Contract controls for raw material consistency (species mix, harvest season, geography).
Documentation that supports contaminant and oxidation risk assessment.

How many suppliers exist for fish oil triglycerides, and what are the main supply regions?

Short answer: The market is broad, but pharma-qualified supply tends to concentrate among refiners and CDMOs with validated purification capacity and consistent specs. Geographic supply commonly spans Asia (refining scale), Europe (regulatory-driven quality systems), and North America (drug development and CGMP packaging/finishing).

Typical regional roles

Asia: large-scale fish oil refining capacity, often with concentration and purification steps.
Europe: GMP and QMS-focused supply relationships for EU drug product development and tech transfer.
North America: frequent presence of softgel CDMOs and pharma-finished product packaging/encapsulation providers.

Which suppliers can provide fish oil triglycerides for softgel drug products?

Short answer: Softgel drug supply generally needs both (1) pharmaceutical-grade omega-3 triglyceride concentrate and (2) a softgel CGMO with validated encapsulation and oxidation-stability controls.

Softgel-specific supply requirements

Lipid compatibility with gelatin or alternative shell systems.
Encapsulation headspace oxygen control where used.
In-process checks for fill uniformity, seal integrity, and leakage.
Stability program support for peroxide rise and shelf-life limits.

What contract manufacturing options exist for fish oil triglycerides: bulk, API, or finished drug product?

Short answer: Sponsors can choose:

Bulk/API supply only: refiners provide triglyceride concentrates.
Intermediate + encapsulation: refiners provide bulk concentrate; CDMO handles conversion to softgels/capsules.
Full finished goods: CDMO integrates compounding, encapsulation, packaging, and release testing under one quality system.

Vendor model implications

Bulk-only models increase sponsor workload for formulation and packaging control.
Full-finished models reduce integration risk but can reduce sponsor flexibility in changing formulations or suppliers.

What due diligence checks reduce supply and regulatory risk for fish oil triglycerides suppliers?

Short answer: Diligence focuses on consistency, contamination controls, analytical method alignment, and change management. The objective is to prevent batch failures, oxidation drift, and regulatory issues tied to impurity profiles.

High-yield diligence items

Confirm supplier release tests match the sponsor spec panel.
Review out-of-spec and deviation rates for comparable lots.
Validate that oxidation control strategy aligns with expected shelf life.
Confirm capacity for surge supply and inventory planning.
Verify ability to support regulatory documentation and tech transfer.

How do fish oil triglycerides suppliers support tech transfer and regulatory submissions?

Short answer: Pharma suppliers typically support:

Analytical comparability packages,
Batch records and method details,
CoA comparability across pilot-to-commercial scale,
Change notifications and regulatory impact assessments.

Tech transfer friction points

Changes in refining method that shift impurity/oxidation profile.
Variability in crude oil composition affecting EPA/DHA ratio or triglyceride profile.
Differences in storage conditions between refining and encapsulation.

Key Takeaways

Fish oil triglycerides is supplied through a two-tier model: upstream omega-3 refiners that produce pharmaceutical-grade triglyceride concentrates and downstream CGMOs that encapsulate and finish drug products.
Supplier qualification is dominated by oxidation control, heavy metal and contaminant testing, and batch-to-batch consistency in EPA/DHA strength and triglyceride identity.
Strong pharma suppliers show CGMP maturity, robust analytical release capability, and change management that supports regulatory submissions and tech transfer.
Softgel drug supply requires both ingredient quality and packaging/encapsulation controls designed to limit oxidation over shelf life.

FAQs

What CGMP certifications should a fish oil triglycerides supplier provide for pharma use?
Look for evidence of GMP manufacturing under a recognized quality system, plus quality agreements that define batch release testing, deviation handling, and change control.
How do suppliers measure oxidation quality in pharmaceutical fish oil triglycerides?
Typically using peroxide value and other oxidation indices such as anisidine-related metrics or composite indices aligned to the sponsor’s spec panel and stability program.
What contaminant tests are most common for drug-grade fish oil triglycerides?
Heavy metals (lead, mercury, cadmium, arsenic) and impurity/oxidation profiles used in the finished product specification.
Can fish oil triglycerides be sourced from multiple suppliers without breaking formulation consistency?
It can, but it requires comparability work that aligns EPA/DHA content, triglyceride identity/composition, and impurity/oxidation profiles.
What’s the difference between dietary omega-3 fish oil and pharmaceutical-grade fish oil triglycerides?
Pharmaceutical-grade products have tighter impurity, contaminant, and oxidation controls, plus stronger CGMP release documentation and batch traceability to support regulatory expectations.

References

[No sources cited.]

Suppliers and packagers for generic pharmaceutical drug: FISH OIL TRIGLYCERIDES